(197 days)
No
The description details a standard oscillometric blood pressure monitor and its components. There is no mention of AI, ML, or any related technologies in the intended use, device description, or performance studies. The methodology described is a traditional signal processing approach.
No.
The device is intended for non-invasive measurement of blood pressure and heart rate, which is a diagnostic function, not a therapeutic one. It provides readings rather than performing treatment.
Yes
A diagnostic device is used to detect, diagnose, or monitor a medical condition. This blood pressure monitor is intended for "non-invasive measuring of an adult individual's systolic, diastolic blood pressure and heart rate," which are essential measurements for monitoring cardiovascular health and diagnosing conditions like hypertension.
No
The device description explicitly lists multiple hardware components (power supply management module, blood pressure data acquisition module, MCU and peripheral, data communication module, data storage module, pump value plate controlling module, program debugging and burning module) and describes a physical measurement process involving an inflatable cuff and oscillometric methodology. While it is software-driven, it is not software-only.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples such as blood, urine, or tissue that have been taken from the human body to detect diseases or other conditions.
- Device Function: The Blood Pressure Monitor CBP111/CBP112 measures blood pressure and heart rate non-invasively on the upper arm. It does not analyze samples taken from the body.
- Intended Use: The intended use is for non-invasive measurement of physiological parameters (blood pressure and heart rate) directly from the body.
- Device Description: The description details a system for measuring blood pressure using an inflatable cuff and oscillometric methodology, which is a physical measurement technique, not an in vitro analysis.
Therefore, the function and intended use of this device clearly fall outside the scope of an In Vitro Diagnostic.
N/A
Intended Use / Indications for Use
The Blood Pressure Monitor CBP111/CBP112 is intended for non-invasive measuring of an adult individual's systolic, diastolic blood pressure and heart rate in home or clinical use. Blood pressure readings should be taken on the upper arm of an adult only, and the suitable cuff size is from 22cm to 32cm.
Product codes
DXN
Device Description
Blood Pressure Monitor CBP111/CBP112 is a non-invasive blood pressure measurement system for use in hospital, at home or clinical use. It is designed to measure the systolic and diastolic blood pressure, and pulse rate of an individual in each measurement and then display the digital readings on LED screen. Blood pressure readings should be taken on the upper arm of an adult only.
The device utilizes the oscillometric methodology, in which an inflatable cuff is wrapped around the upper arm of an individual, for blood pressure measurement. This means the monitor detects your blood's movement through your brachial artery and converts the movement into a digital reading on LED screen.
The proposed device CBP111/CBP112 has the following components: power supply management module, blood pressure data acquisition module, MCU and peripheral, data communication module, data storage module, pump value plate controlling module and program debugging and burning module.
The Blood Pressure Monitor CBP111 and CBP112 have the same electrical circuit and structure design. They have the same accessories. They also have the same display type, control module and communication module. The difference between them is the measurement type. The CBP111 is reading the data while it is deflating. The CBP112 is reading the data while it is inflating.
The proposed device is not for life-supporting or life-sustaining, not for implant.
The device is not sterile and the transducers are reusable and do not need sterilization and re-sterilization.
The device is for over the counter use.
The device does not contain drug or biological products.
The device is software-driven and software validation is provided in software.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
upper arm
Indicated Patient Age Range
adult
Intended User / Care Setting
home or clinical use
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Clinical Test Summary: Testing to insure clinical accuracy of proposed devices in accordance with ISO 81060-2:2013 Non-invasive sphygmomanometers-Part 2: Clinical validation of automated measurement type as documented in Clinical Study Report. 85 patients (42 females and 43 males) were invited for the study. Standard auscultation method was used as the reference blood pressure monitor measuring in the left arm. Blood pressure measurements were repeated alternatively with the device and auscultation in the same arm according to the sequence in ISO81060-2:2013.
Non-Clinical Test Summary: The subject device CBP111 was tested to evaluate its safety and effectiveness, including the following:
a. EMC Test: IEC 60601-1-2:2007
b. Safety Test: IEC 60601-1:2012, IEC 60601-1-11:2010
c. FCC Test: FCC 47 CFR Part 15, Subpart B
d. Biocompatibility Test: ISO 10993-1:2009, ISO 10993-5:2009, ISO 10993-10:2010 (The proposed blood pressure cuff selects the materials of the blood pressure cuff which has been cleared by FDA with the premarket notification number K151810.)
e. Reliability Test: IEC 80601-2-30:2013
f. Software Verification and Validation: IEC 62304: 2006
The Blood Pressure Monitor CBP112 and CBP111 have the same electrical circuit and structure design, accessories, display type, control module and communication module. The difference between them is the measurement type (CBP111 reading data while deflating; CBP112 reading data while inflating). CBP111 laboratory test results were used to support clearance of proposed device CBP112. The test results indicated that the safety and effectiveness of the proposed device is identical to that of the predicate device.
Key Metrics
Blood pressure measurement accuracy: +/- 3mmHg
Pulse rate measurement accuracy: >60bpm +/- 5%,
§ 870.1130 Noninvasive blood pressure measurement system.
(a)
Identification. A noninvasive blood pressure measurement system is a device that provides a signal from which systolic, diastolic, mean, or any combination of the three pressures can be derived through the use of tranducers placed on the surface of the body.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/1 description: The image shows the logo for the Department of Health & Human Services - USA. The logo is a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is an abstract image of a stylized eagle or bird-like figure, with three overlapping profiles facing to the right.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
February 10, 2017
Beijing Choice Electronic Technology Co., Ltd. Lei Chen Quality Director No.9 Shuangyuan Road, Badachu Hi-tech Zone, Shijingshan District Beijing, 100041 CN
Re: K162089
Trade/Device Name: Blood Pressure Monitor CBP111/CBP112 Regulation Number: 21 CFR 870.1130 Regulation Name: Noninvasive Blood Pressure Measurement System Regulatory Class: Class II Product Code: DXN Dated: January 3, 2017 Received: January 6, 2017
Dear Lei Chen:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in
1
the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely.
Mache Jellison
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K162089
Device Name Blood Pressure Monitor CBP111/CBP112
Indications for Use (Describe)
The Blood Pressure Monitor CBP111/CBP112 is intended for non-invasive measuring of an adult individual's systolic, diastolic blood pressure and heart rate in home or clinical use. Blood pressure readings should be taken on the upper arm of an adult only, and the suitable cuff size is from 22cm to 32cm.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| ------------------------------------------------- | -- |
Prescription Use (Part 21 CFR 801 Subpart D)
|X | Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Section III 510(k) Summary
This summary of 510(k) is being submitted in accordance with the requirements of 21 CFR 807.92.
There is no prior submission for the device.
3.1 Submitter Information
Manufacturer Name:
Establishment Registration Number: 3005569927 Beijing Choice Electronic Technology Co., Ltd. Room 4104,No.A12 Yuquan Road Haidian District 100143 Beijing, P.R.China
Contact Person:
Mr. Lei Chen Beijing Choice Electronic Technology Co., Ltd. North Building 3F, No. 9 Shuangyuan Road, Badachu Hi-tech Zone, Shijingshan District Beijing China 100041 Phone: +86-10-88798300 Ext 6020 Fax:215-4052545 Email: cc@choicemmed.com
Date prepared: July 22, 2016
3.2 Proposed Device Information
Device Common Name: Non-invasive Blood Pressure Measurement System Device Trade/Proprietary Name: Blood Pressure Monitor Model: CBP111, CBP112 Classification Name: Non-invasive Blood Pressure Measurement System Regulation Number: 870.1130 Product Code: DXN Class: II Panel: Cardiovascular
3.3 Predicate Device
510(k) Number: K143735 Common Name: Noninvasive Blood Pressure Measurement System
4
Premarket Notification 510(k) Submission-Section III 510(k) Summary Device Trade/Proprietary Name: Digital Automatic Blood Pressure Monitor Model: MD2300 Classification Name: Non-invasive Blood Pressure Measurement System Regulation Number: 870.1130 Product Code: DXN Class: II Manufacturer: GRANDWAY TECHNOLOGY (SHENZHEN) LIMITED Intended Use: The upper arm blood pressure monitor is used for non-invasive measurement and monitoring for adults arterial blood pressure. You can use it to measure your systolic and diastolic pressure, and pulse rate through an inflatable cuff wrapped
3.4 Device Description
progression of readings together with the average.
Blood Pressure Monitor CBP111/CBP112 is a non-invasive blood pressure measurement system for use in hospital, at home or clinical use. It is designed to measure the systolic and diastolic blood pressure, and pulse rate of an individual in each measurement and then display the digital readings on LED screen. Blood pressure readings should be taken on the upper arm of an adult only.
around the upper arm. Quickly and easily, storing the results and displaying the
The device utilizes the oscillometric methodology, in which an inflatable cuff is wrapped around the upper arm of an individual, for blood pressure measurement. This means the monitor detects your blood's movement through your brachial artery and converts the movement into a digital reading on LED screen.
The proposed device CBP111/CBP112 has the following components: power supply management module, blood pressure data acquisition module, MCU and peripheral, data communication module, data storage module, pump value plate controlling module and program debugging and burning module.
The Blood Pressure Monitor CBP111 and CBP112 have the same electrical circuit and structure design. They have the same accessories. They also have the same display type, control module and communication module. The difference between them is the measurement type. The CBP111 is reading the data while it is deflating. The CBP112 is reading the data while it is inflating.
The proposed device is not for life-supporting or life-sustaining, not for implant.
The device is not sterile and the transducers are reusable and do not need sterilization and re-sterilization.
The device is for over the counter use.
The device does not contain drug or biological products.
5
The device is software-driven and software validation is provided in software.
3.5 Indications for use
The Blood Pressure Monitor CBP111/CBP112 is intended for non-invasive measuring of an adult individual's systolic, diastolic blood pressure and heart rate in hospital, at home or clinical use. Blood pressure readings should be taken on the upper arm of an adult only, and the suitable cuff size is from 22cm to 32cm.
6
3.6 Comparison of Technology Characteristics with the Predicate Device
Blood Pressure Monitor CBP11 is compared to the predicate device, Digital Automatic Blood Pressure MD2300 (K143735) in the device comparison table below
| Comparison between Blood Pressure Monitor CBP111 and Predicate Device | |||
|---|---|---|---|
| Item | Predicate Device | Proposed Device(CBP111) | Proposed Device(CBP112) |
| Indication for use | The upper arm blood pressure monitor is used for non-invasive measurement and monitoring for adults arterial blood pressure. You can use it to measure your systolic and diastolic pressure, and pulse rate through an inflatable cuff wrapped around the upper arm. Quickly and easily, storing the results and displaying the progression of readings together with the average. | The Blood Pressure Monitor CBP111 is intended for non-invasive measuring of an adult individual's systolic, diastolic blood pressure and heart rate in hospital, at home or clinical use. Blood pressure readings should be taken on the upper arm of an adult only. | The Blood Pressure Monitor CBP112 is intended for non-invasive measuring of an adult individual's systolic, diastolic blood pressure and heart rate in hospital, at home or clinical use. Blood pressure readings should be taken on the upper arm of an adult only. |
| Measurement method | Non-invasive, Oscillometric | Non-invasive, Oscillometric | Non-invasive, Oscillometric |
| IHB Detection | Yes | No | No |
| Patient population | Adult | Adult | Adult |
| BP measurement range | Cuff pressure: 0~300 mmHg | Cuff pressure: 0~280 mmHg | Cuff pressure: 0~280 mmHg |
| Number of user | 2 independent users | Record the last results and do not distinguish the people | Record the last results and do not distinguish the people |
| Memory space | 2 users x 60 memory space | 2k byte (24C16) | 2k byte (24C16) |
| Resolution of | |||
| measurement | Blood pressure: 1mmHg | ||
| Pulse rate: 1beat/min | Blood pressure: 1mmHg | ||
| Pulse rate: 1beat/min | Blood pressure: 1mmHg | ||
| Pulse rate: 1beat/min | |||
| Blood pressure | |||
| measurement accuracy | $\pm$ 3mmHg | $\pm$ 3mmHg | $\pm$ 3mmHg |
| Pulse rate measurement | |||
| range | 40-180 beats/min | 40-180bpm | 40-180bpm |
| Pulse rate measurement | |||
| accuracy | $\pm$ 5% of reading | >60bpm $\pm$ 5%, $\le$ 60bpm, $\pm$ 3bpm | >60bpm $\pm$ 5%, $\le$ 60bpm, $\pm$ 3bpm |
| Display type | LCD | LED | LED |
| Power source | 4 x1.5V AA-batteries and/or AC adapter | 4 AA alkaline batteries | 4 AA alkaline batteries |
| Pressurization mode | Automatic inflation | Automatic inflation | Automatic inflation |
| Deflation mode | Automatic exhaust/Deflation | Automatic exhaust/Deflation | Automatic exhaust/Deflation |
| Operating condition | Temperature: +5℃ to 40℃ | ||
| Humidity: 15% to 93% R.H. max | |||
| Atmosphere pressure: 700-1060hPa | Temperature: +5℃ to 40℃ | ||
| Humidity: 15% to 93% R.H. max | |||
| Atmosphere pressure: 700-1060hPa | Temperature: +5℃ to 40℃ | ||
| Humidity: 15% to 93% R.H. max | |||
| Atmosphere pressure: 700-1060hPa | |||
| Storage | |||
| and | |||
| transportation condition | Temperature: -25°C to 70°C | ||
| Humidity: up to 93% R.H. max | |||
| Atmosphere pressure: | |||
| 700-1060hPa | Temperature: -25°C to 70°C | ||
| Humidity: up to 93% R.H. max | |||
| Atmosphere pressure: | |||
| 700-1060hPa | Temperature: -25°C to 70°C | ||
| Humidity: up to 93% R.H. max | |||
| Atmosphere pressure: | |||
| 700-1060hPa | |||
| Material | Resistances, capacitances, | ||
| transistors, Amplifiers, pressure | |||
| sensor, CPU, PCB, cuff, ABS | |||
| button, ABS cabinet, batteries and | |||
| packaging | Resistances, capacitances, | ||
| transistors, Amplifiers, pressure | |||
| sensor, CPU, PCB, cuff, ABS | |||
| button, ABS cabinet, batteries and | |||
| packaging | Resistances, capacitances, | ||
| transistors, Amplifiers, pressure | |||
| sensor, CPU, PCB, cuff, ABS | |||
| button, ABS cabinet, batteries and | |||
| packaging | |||
| Compatibility | |||
| with | |||
| environment and other | |||
| devices | No influence with environment | ||
| and other device | No influence with environment | ||
| and other device | No influence with environment | ||
| and other device | |||
| Applicable standard | -EN 1060-1:1995+A2:2009 | ||
| -EN 1060-3:1997+A2:2009 | |||
| -IEC 60601-1: 2012 | |||
| -IEC 60601-1-2:2007 | |||
| -FCC Part 15 Subpart B | |||
| -ISO 10993-5:2009 | |||
| -ISO 10993-10:2010 | |||
| -IEC 62304:2006 | -IEC 60601-1: 2012 | ||
| -IEC 60601-1-2:2007 | |||
| -IEC 60601-1-11:2010 | |||
| -FCC Part 15 Subpart B | |||
| -ISO 10993-5:2009 | |||
| -ISO 10993-10:2010 | |||
| -IEC 62304:2006 | |||
| -ISO 81060-2:2013 | -IEC 60601-1: 2012 | ||
| -IEC 60601-1-2:2007 | |||
| -IEC 60601-1-11:2010 | |||
| -FCC Part 15 Subpart B | |||
| -ISO 10993-5:2009 | |||
| -ISO 10993-10:2010 | |||
| -IEC 62304:2006 | |||
| -ISO 81060-2:2013 | |||
| -IEC 81060-2:2013 | -IEC 80601-2-30: 2013 | -IEC 80601-2-30: 2013 |
7
8
Premarket Notification 510(k) Submission-Section III 510(k) Summary
9
Blood Pressure Monitor CBP11/CBP112 is a non-invasive measuring device and utilizes the oscillometric methodology to measure the blood pressure reading. The key components of the device are: blood pressure data acquisition module, MCU and peripheral, data communication module, data storage module, pump valve . The predicate device adopts exactly same methodology and key components for measuring blood pressure.
10
3.7 Clinical and Non-clinical Tests
Clinical Test Summary
Testing to insure clinical accuracy of proposed devices in accordance with ISO 81060-2:2013 Non-invasive sphygmomanometers-Part 2: Clinical validation of automated measurement type as documented in Clinical Study Report.
85 patients (42 females and 43 males) were invited for the study. Standard auscultation method was used as the reference blood pressure monitor measuring in the left arm. Blood pressure measurements were repeated alternatively with the device and auscultation in the same arm according to the sequence in ISO81060-2:2013.
Non-Clinical Test Summary
The subject device CBP111 was tested to evaluate its safety and effectiveness, including the following:
a. EMC Test: IEC 60601-1-2:2007 Medical Electrical Equipment- Part 1-2: General requirements for safety- collateral standard: Electromagnetic compatibility-Requirements and tests.
b. Safety Test:
-IEC 60601-1:2012 Medical electrical equipment - Part 1: General requirements for basic safety and essential performance.
-IEC 60601-1-11:2010 Medical electrical equipment- Part 1-11: General requirements for basic safety and essential performance-Collateral Standard: Requirements for medical electrical systems used in the home healthcare environment.
c. FCC Test:
FCC 47 CFR Part 15, Subpart B
d. Biocompatibility Test:
The proposed blood pressure cuff selects the materials of the blood pressure cuff which has been cleared by FDA with the premarket notification number K151810. The materials of cuff meet the requirements of the following standards:
-ISO 10993-1:2009, Biological evaluation of medical devices -Part 1: Evaluation and testing within a risk management process.
-ISO 10993-5:2009 Biological evaluation of medial devices -Part 5: Test for In Vitro cytotoxicity.
-ISO 10993-10:2010 Third Edition Biological evaluation of medial devices -Part 10: Tests for irritation and skin sensitization.
11
Premarket Notification 510(k) Submission-Section III 510(k) Summary e. Reliability Test:
IEC 80601-2-30:2013 Medical electrical equipment-Part 2-30: Particular requirements the basic safety and essential performance of automated non-invasive for sphygmomanometers.
f. Software Verification and Validation
IEC 62304: 2006 Medical device software - Software life cycle processes.
The Blood Pressure Monitor CBP112 and CBP111 have the same electrical circuit and structure design. They have the same accessories. They also have the same display type, control module and communication module. The difference between them is the measurement type. The CBP111 is reading the data while it is deflating. The CBP112 is reading the data while it is inflating. So we think CBP111 laboratory test results can be used to support clearance of proposed device CBP112.
The subject device was tested and fulfilled the requirements of those standards mentioned above. The test results indicated that the safety and effectiveness of the proposed device is identical to that of the predicate device.
3.8 Conclusion
The proposed device Blood Pressure Monitor CBP111/CBP112 and predicate device have the same classification information, similar intended use, same design method, similar product design and specifications, and the similar performance as the predicated device. The main difference is that the predicated device has function of IHB detection while the proposed device does not. The difference does not influence the effectiveness and safety of the proposed device. According to the test results, the proposed device is as safe and as effective as the predicate device. So the proposed device is Substantially Equivalent (SE) to the predicate device which is US legally market device.